Reshma Ashda Lalvani, a promoter of Ador Welding , has confirmed that she and persons acting in concert have not created any encumbrance on the shares held by them during the financial year 2025-26. This disclosure ensures that the promoter's shareholding remains free from charges or liens, which is critical for maintaining transparency in shareholding patterns.

The confirmation was submitted to the stock exchanges on April 1, 2026, in compliance with Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The regulation mandates promoters to disclose any encumbrance on their holdings to safeguard shareholder interests.

The filing was addressed to BSE Ltd. and the National Stock Exchange of India Ltd., with a copy marked to the Chairman of the Audit Committee of Ador Welding Limited. The confirmation covers both direct and indirect encumbrances, providing a comprehensive view of the promoter's financial commitments regarding the company's shares.

Ador Welding has approved the second grant of stock options under its Ador Employee Stock Option Plan 2025. The Nomination and Remuneration Committee, acting as the Compensation Committee, sanctioned the allotment of 36,800 stock options to 75 eligible employees during a meeting held on May 25, 2026.

Grant Details

The options are granted in compliance with the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The total number of shares covered by these options is 36,800 equity shares, each with a face value of Rs. 10.

Pricing and Vesting

The exercise price for the options has been determined at Rs. 10 per share or option. The options are subject to a vesting period of a minimum of one year from the date of the grant. All options granted will vest according to the conditions specified in the respective grant letters issued to the employees.

Key Terms of the Grant

The scheme is implemented directly by the company through the Board or the Nomination and Remuneration Committee. The exercise period for these options is set at three years from the date of vesting.